- Home
- SNES
SNES
SenesTech Inc.
as of 12-09-2025 1:04pm EST
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | PHOENIX |
| Market Cap: | 14.5M | IPO Year: | 2016 |
| Target Price: | $10.00 | AVG Volume (30 days): | 69.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.30 - $6.24 | Next Earning Date: | 11-10-2025 |
| Revenue: | $2,301,000 | Revenue Growth: | 39.37% |
| Revenue Growth (this year): | 41.52% | Revenue Growth (next year): | 77.28% |
Stock Insider Trading Activity of SenesTech Inc. (SNES)
Director
Avg Cost/Share
$2.71
Shares
62
Total Value
$168.02
Owned After
0
SEC Form 4
Director
Avg Cost/Share
$2.75
Shares
1
Total Value
$2.75
Owned After
0
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Leach Jacob Steven | SNES | Director | Nov 18, 2025 | Sell | $2.71 | 62 | $168.02 | 0 | |
| Szot Matthew K | SNES | Director | Nov 14, 2025 | Sell | $2.75 | 1 | $2.75 | 0 |
Compare SNES vs Leading Stocks
See how SNES stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SNES SenesTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.